Lupin share price gains on USFDA nod for Mycophenolic drug With this approval, the company said it would market a generic equivalent of Myfortic delayed release tablets of Novartis Pharmaceuticals Corporation,
Feedback
LUPIN 
Reputation: 2,149 • Dec 20, 2019 3:00 AM
Vote
Comment
Share